Tyra Announces Pricing of Upsized Initial Public Offering
CARLSBAD, Calif., Sept. 14, 2021 /PRNewswire/ — Tyra Biosciences, Inc. (Nasdaq: TYRA), a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer, today announced the…
